Skip to Main Content

Hematology & Oncology

* (Pediatric Hematology & Oncology Profile)

Ali Sanati-Mehrizy

Ali Sanati-Mehrizy, MD

Contact Info

  • 2 Tampa General Circle
    STC 5th Floor
    Tampa FL 33606
  • Academic Email: as3@usf.edu
  • Academic Phone: (813) 821-8029

Education

  • MD, Medicine, Pennsylvania State University, 2012
  • HBS, Biology, University of Utah, 2008

Memberships

  • Member (Children's Oncology Group, 2020 - Present)

Recent Publications

  • Sanati-Mehrizy A, Ghosh T, Peterson E, Starke RM, Harbour JW, Corrales-Medina FF. Hematologic Complications Associated With Intra-arterial Chemotherapy for Retinoblastoma Treatment: A Single Institution Experience. Journal of pediatric hematology/oncology. 44(4) : 181-185, 2022.
  • Ghahramani N, Sanati-Mehrizy A, Wang C. Perceptions of patient candidacy for kidney transplant in the United States: a qualitative study comparing rural and urban nephrologists. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 12(1) : 9-14, 2014.
  • Ghahramani N, Wang C, Sanati-Mehrizy A, Tandon A. Perception about transplant of rural and urban patients with chronic kidney disease; a qualitative study. Nephro-urology monthly. 6(2) : e15726, 2014.
  • Ridges S, Heaton WL, Joshi D, Choi H, Eiring A, Batchelor L, Choudhry P, Manos EJ, Sofla H, Sanati A, Welborn S, Agarwal A, Spangrude GJ, Miles RR, Cox JE, Frazer JK, Deininger M, Balan K, Sigman M, Müschen M, Perova T, Johnson R, Montpellier B, Guidos CJ, Jones DA, Trede NS. Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 119(24) : 5621-31, 2012.

Positions Held

  • Chief Fellow (Pediatric Hematology and Oncology, University of Miami 2018 - 2020)
  • Chief Resident (Pediatrics, Rutgers University New Jersey Medical School 2016 - 2017)